Successful treatment of a refractory intestinal Behcet’s disease with an oncology history by Vedolizumab: a case report and literature review

Successful treatment of a refractory intestinal Behcet’s disease with an oncology history by Vedolizumab: a case report and literature review

ObjectiveBehçet’s Disease (BD) is an intractable systemic vasculitis. When accompanied by intestinal symptoms, the prognosis is usually poor. 5-Aminosalicylic acid (5-ASA), corticosteroids, immunosuppressive drugs, and anti-tumor necrosis factor-α (anti-TNF-α) biologics are standard therapies to ind...

Full description

Bibliographic Details
Main Authors: Ruixia Li, Xiaofei Li, He Zhou, Yanting Shi, Fang Wang, Tong Wu, Jie Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
Behcet’s disease
intestinal disease
vedolizumab
tumor
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1205046/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1205046/full

Similar Items